Octave® Bioscience, Inc. was honored in Fast Company’s Innovation by Design Awards for 2023 in the Health category. The Innovation by Design Awards, which can be found in the September 2023 issue of Fast Company, honor the designers and businesses solving the most crucial…
The global vital signs monitoring devices market is expected to reach a value of $33.36 billion by 2028 from $20.6 billion in 2022, growing at a CAGR of 8.36% from 2022 to 2028 The North American region dominated the vital…
inSpring, a leading health care and technology talent mobility company specializing in connecting diverse, highly-skilled international job candidates in the United States with employment opportunities in nursing and technology, announced today a groundbreaking partnership with Mass General Brigham’s esteemed graduate school, MGH Institute…
Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm, has launched a research study assessing providers of digital services for the healthcare industry. The study results will be published in a comprehensive ISG Provider Lens™ report…
The Foundation for the National Institutes of Health (FNIH) has awarded its sixth annual Trailblazer Prize for Clinician-Scientists to Vinod Balachandran, M.D., at Memorial Sloan Kettering Cancer Center (MSK), for his groundbreaking research on immunotherapies for pancreatic cancer. The FNIH’s Trailblazer…
eClinicalWorks®, the largest ambulatory cloud EHR, today announced that Global Open Wound Care—a mobile wound care clinic specializing in advanced wound treatments and point-of-care treatment decision-making—has selected eClinicalWorks EHR to enhance patient care, mobility, and practice efficiency. Global Open Wound Care…
In the wake of the devastation caused by the wildfires in Hawaii, Henry Schein, Inc. (Nasdaq: HSIC) is raising money for recovery and rebuilding efforts, donating much-needed health care supplies, and supporting its customers who may be impacted by the ongoing crisis. The…
Novartis today issued the invitation to an Extraordinary General Meeting (EGM) of Novartis shareholders, scheduled to take place on September 15, 2023, in relation to the proposed 100% Spin-off of Sandoz, the Generics and Biosimilars business of Novartis. At the…
AbbVie (NYSE: ABBV) today announced that the European Commission has approved AQUIPTA® (atogepant) for the prophylaxis of migraine in adults who have four or more migraine days per month. The approval makes AQUIPTA the first and only once-daily oral calcitonin gene-related…
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed Stephen (Steve) H. Rusckowski, former chairman, president and chief executive officer of Quest Diagnostics, Inc., to its board of directors. Effective today, Mr. Rusckowski serves on Baxter’s…
AstraZeneca and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that LYNPARZA in combination with abiraterone and prednisone or prednisolone (abi/pred) has been approved in Japan for the treatment of adult patients with BRCA-mutated…
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced topline results from LITESPARK-005, the first positive Phase 3 trial investigating WELIREG, Merck’s oral hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor. LITESPARK-005 is evaluating WELIREG for the…